Jiangsu Hengrui reported CNY5.52B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Sh Fosun Pharma CNY 9.18B 2.12B Mar/2026
Sh Pharmaceutical CNY 66.41B 5.25B Dec/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Wuxi Apptec CNY 7.33B 511.69M Mar/2026
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026